Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis

Assiut University

Status: Unknown

Conditions: Behcet's Syndrome, Vascular Type

Treatments: Drug: Hydroxychloroquine

Study type: Interventional

Funder types: Other

Identifiers

NCT04022421

17300279

Details and patient eligibility

About

Patients diagnosed with Behcet's disease will be randomized to administeration of hydroxychloroquine. Assessment will be done for the patients at baseline and every one month in the first three months and then quarterly for one year.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients diagnosed with Behcet's disease on any DMARDs

Exclusion criteria

• Patients with critical conditions
• Patients with hypersensitivity or adverse drug reactions to hydroxychloroquine.

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

hydroxychloroquine arm

Experimental group

Treatment:

Drug: Hydroxychloroquine